Continuing Medical Education
Cleveland Clinic Center for Continuing Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2021 Annual Meeting
- Achieving Cost-Effectiveness with Adjuvant Osimertinib for NSCLC
- Upfront Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
- Adjuvant Pembrolizumab Improves Relapse-Free Survival in Patients with High-Risk Resected Melanoma
- Disparities in Government and Nonprofit Funding Affect Cancers with High Mortality Rates
- New Drug Holds Promise for Rare Neuroendocrine Tumors
- New Polygenic Risk Score for Breast Cancer Accurate for All Ancestries
- Mechanical Ventilation Rates in Oncology Patients with COVID-19
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2021 Annual Meeting
- 18F Fluciclovine PET CT Helps Distinguish Radiation Necrosis from Brain Tumor Progression
- Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas
- Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS
- Optimizing Stereotactic Body Radiation Therapy for Pediatric Sarcoma
- Study Identifies Prognostic Subgroups in Cutaneous Squamous Cell Carcinoma
American Society of Hematology (ASH)
Featured Abstracts from the 2021 Annual Meeting
- Modified Drug Regimen May Reduce Risks in Allogeneic Hematopoietic Cell Transplant Patients
- Biomarkers Predict Outcomes of CAR T-Cell Therapy in Patients with Diffuse Large B-Cell Lymphoma
- Addition of CAEL-101 to Anti-Plasma Cell Dyscrasia Therapy May Have Long-Term Benefits in Patients with AL Amyloidosis
- Immune Checkpoint Inhibitors May Enhance Cancer-Associated Thrombosis
- New Drug Combination Can Extend the Lives of Older Patients with Ph+ Acute Lymphoblastic Leukemia
- Newly Identified Risk Factors Help Predict How Aplastic Anemia Can Become Malignant
